NCT06836453View on ClinicalTrials.gov

Evaluation of New Device for Beta-adrenergic Sweat Test in the Context of Stratification of Patient With Cystic Fibrosis

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 1, 2029

Study Completion Date

June 1, 2029

Conditions
Cystic Fibrosis
Interventions
DEVICE

Sweat stimulation and secretion quantification

"First session (50 minutes): a. Left arm: Iontophoresis using the Macroduct for the cholinergic and β-adrenergic stimulation (2 iontophoresis), then bubble test. b. right arm: Iontophoresis using the Macroduct for the cholinergic and β-adrenergic stimulation (2 iontophoresis), then evaporimetry.~Second session (50 minutes): a. Left arm: Iontophoresis using the Macroduct for the cholinergic and intradermal injection for the β-adrenergic stimulation, then bubble test. b. Right arm: Iontophoresis using the Macroduct for the cholinergic and intradermal injection for the β-adrenergic stimulation, then evaporimetry."

Trial Locations (1)

1200

RECRUITING

Cliniques Universitaires Saint-Luc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER